Want to see AVAH full AI Analyst Report?
AVAH Stock Chart & Stats
$6.77
$0.12(2.70%)
At close: 4:00 PM EST
$6.77
$0.12(2.70%)
Day’s Range― - ―
52-Week Range$3.73 - $10.32
Previous CloseN/A
Volume95.00K
Average Volume (3M)2.17M
Market Cap
$2.14B
Enterprise Value$2.95B
Total Cash (Recent Filing)$189.27M
Total Debt (Recent Filing)$1.50B
Price to Earnings (P/E)7.7
Beta1.25
Next Earnings
Aug 06, 2026EPS Estimate
0.17Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.27
Shares Outstanding217,755,200
10 Day Avg. Volume2,441,737
30 Day Avg. Volume2,165,070
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)8.46
Price to Sales (P/S)0.68
P/FCF Ratio14.33
Enterprise Value/Market Cap1.38
Enterprise Value/Revenue1.17
Enterprise Value/Gross Profit3.59
Enterprise Value/Ebitda9.88
Forecast
1Y Price Target
$10.13Price Target Upside49.56% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
EPS Forecast (FY)0.71
Revenue Forecast (FY)$2.62B
Bulls Say, Bears Say
Bulls Say
Improved Profitability And MarginsAveanna’s return to positive net income and mid‑single digit+ net and ~10% EBIT margins shows sustained operational improvement. Durable margin expansion reflects pricing, efficiency and scale gains that improve cash generation, resilience to reimbursement shifts, and ability to fund investments and deleveraging over time.
Strengthening Cash GenerationConsistent positive operating and free cash flow across the latest annual period and TTM signals improved earnings quality and convertibility. Reliable cash generation supports working capital, modest organic growth, M&A funding, and gradual debt reduction, increasing long‑term financial flexibility if sustained.
Scale Expansion Via Strategic M&A And Preferred‑Payer WinsThe Family First acquisition and continued preferred‑payer wins materially expand pediatric footprint and operational density. Greater scale and preferred contracts improve pricing leverage, caregiver hiring economics, and route density—structural drivers that can raise margins and accelerate organic growth across markets over several quarters.
Bears Say
High Leverage And Debt LoadSubstantial debt and a debt‑heavy capital structure constrain flexibility: high interest exposure, covenant and refinancing risk, and limited capacity to absorb reimbursement or labor shocks. Even with improving cash flow, meaningful deleveraging will require sustained FCF and disciplined capital allocation over multiple quarters.
Persistent Labor Cost PressureRising labor costs compress the spread/hour and can erode gross margins absent commensurate rate recovery. The business depends on recruiting/retaining clinicians; wage inflation and competitive pay dynamics are structural headwinds that require negotiated rate increases or productivity gains to maintain durable profitability.
Regulatory Uncertainty In Home HealthIndustry‑level regulatory actions increase execution risk: moratoria and heightened scrutiny can slow organic growth, complicate M&A approvals, and raise compliance costs. For a company reliant on Medicare/Medicaid reimbursement, sustained regulatory tightening could structurally limit addressable volume and delay rate negotiations.
Aveanna Healthcare Holdings News
AVAH FAQ
What was Aveanna Healthcare Holdings Inc’s price range in the past 12 months?
Aveanna Healthcare Holdings Inc lowest stock price was $3.73 and its highest was $10.32 in the past 12 months.
What is Aveanna Healthcare Holdings Inc’s market cap?
Aveanna Healthcare Holdings Inc’s market cap is $2.14B.
When is Aveanna Healthcare Holdings Inc’s upcoming earnings report date?
Aveanna Healthcare Holdings Inc’s upcoming earnings report date is Aug 06, 2026 which is in 26 days.
How were Aveanna Healthcare Holdings Inc’s earnings last quarter?
Aveanna Healthcare Holdings Inc released its earnings results on May 14, 2026. The company reported $0.18 earnings per share for the quarter, beating the consensus estimate of $0.125 by $0.055.
Is Aveanna Healthcare Holdings Inc overvalued?
According to Wall Street analysts Aveanna Healthcare Holdings Inc’s price is currently Undervalued.
Does Aveanna Healthcare Holdings Inc pay dividends?
Aveanna Healthcare Holdings Inc does not currently pay dividends.
What is Aveanna Healthcare Holdings Inc’s EPS estimate?
Aveanna Healthcare Holdings Inc’s EPS estimate is 0.17.
How many shares outstanding does Aveanna Healthcare Holdings Inc have?
Aveanna Healthcare Holdings Inc has 217,755,200 shares outstanding.
What happened to Aveanna Healthcare Holdings Inc’s price movement after its last earnings report?
Aveanna Healthcare Holdings Inc reported an EPS of $0.18 in its last earnings report, beating expectations of $0.125. Following the earnings report the stock price went up 9.897%.
Which hedge fund is a major shareholder of Aveanna Healthcare Holdings Inc?
Currently, no hedge funds are holding shares in AVAH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Aveanna Healthcare Holdings Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$10.13 (49.56% Upside)
$10.13 (49.56% Upside)
Blogger Sentiment
Bullish
AVAH Sentiment 70%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Decreased
By 336.5K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $215.6M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 8.3%
Last 30 Days ▲ 13.9%
Last 30 Days ▲ 13.9%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
129.97%
12-Months-Change
Fundamentals
Return on Equity
241.47%
Trailing 12-Months
Asset Growth
21.76%
Trailing 12-Months
Company Description
Aveanna Healthcare Holdings Inc
Aveanna Healthcare Holdings Inc. operates as a diverse platform for home-based care services throughout the United States. The company delivers a range of critical offerings, including private duty nursing (PDN), adult home health and hospice care, in-home pediatric therapy, and enteral nutrition services. Its patient-centered approach allows individuals to receive essential medical care within their own homes, effectively reducing the need for costly institutional settings such as hospitals. The company's operations are structured into three key segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment provides specialized private duty nursing, which includes skilled nursing care for medically fragile children at home, nursing support in school environments, and services at pediatric day healthcare centers. This segment also offers employer-of-record support, personal care services, and pediatric therapy (physical, occupational, and speech) provided both in clinics and patients' residences. The HHH segment focuses on home health services, encompassing in-home skilled nursing, physical, occupational, and speech therapy, as well as medical social work and aide assistance. Furthermore, it delivers hospice services, offering compassionate care to patients and their families when life-limiting illnesses no longer respond to curative treatments. The MS segment supplies enteral nutrition products and other vital medical supplies to adults and children, distributed on either a scheduled or as-needed basis. Founded in 2016, Aveanna Healthcare Holdings Inc. is headquartered in Atlanta, Georgia.
AVAH Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed a broadly positive operational and financial trajectory: strong double-digit revenue growth, outsized EBITDA improvement, expanding preferred-payer penetration across all segments, improved collections from RCM/automation, and a raised full-year guidance. Key risks discussed include ongoing labor cost pressure (partially mitigated via rate wins and wage pass-throughs), Q1 seasonality and one-time timing items that affect comparability, weather disruption, regulatory scrutiny in the industry, and the need to continue deleveraging. On balance, management presented tangible execution wins and prudent caution around known headwinds.View all AVAH earnings summariesAVAH Stock 12 Month Forecast
Average Price Target
$10.13
▲(49.56% Upside)
Technical Analysis
Ownership Overview
43.25% Insiders
6.51% Mutual Funds
0.47% Other Institutional Investors
43.56% Public Companies and
Individual Investors